Did you notice, that under past actual, they have 0.33 for June qtr. (which was result for 6 months). What kind of quarter did analysts expect, given what is going on? I was a little disappointed that China is not more significant yet, and no one asked about more exotic products like nanotech.
It looks like they fixed that quarter, but are still showing $0.60 for Q3 2008. That Q was lowered after the fact due to Indian JV losses to $0.06.
They are still at least earning the dividends of $0.72 per year. It may tell you what the board expects upcoming quarters to look like when they make their next dividend decision. If they think earnings are close to recovering, they will maintain the dividend. I picked up a few more shares after the earnings report hoping for a short term trade on those shares.
Wedbush Morgan (Al Kaschalk, see below) lowered their 2009 estimate to $0.87 full year and their 2010 estimate to $1.09. These analysts were nowhere close on the downside and will probably be off just as much on the upside whenever it comes.
July 27, 2009 9:40 AM EDT (Probably Al Kaschalk) Wedbush Morgan downgrades AMCOL International (NYSE: ACO) to Underperform. Lowering price target to $17 from $20.
Wedbush analyst says, "downgrading to UNDERPERFORM as end market volumes expected to remain weak; debt covenant an increasing concern. Minerals segment revenue was down 29.5% while operating margin of 8.0% was 70 bps above our estimate. Joint ventures and affiliates continue to struggle. Reducing our expectations for a recovery until 2010. Adjusting our revenue/EPS estimates to $737.8 million/$0.87 from $811.6 million/$1.02 in 2009 and to $753.9 million/$1.09 from $837.4 million/$1.23 in 2010."